These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6331040)

  • 1. Foetal exposure to low doses of cyproterone acetate in the rat leads to functional endocrine abnormalities despite normal sexual morphogenesis.
    Gómez F; Monnier B; Lemarchand-Béraud T
    Acta Endocrinol (Copenh); 1984 Jul; 106(3):411-9. PubMed ID: 6331040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modifications of the gonadal function in the adult rat after fetal exposure to spironolactone.
    Jaussan V; Lemarchand-Béraud T; Gómez F
    Biol Reprod; 1985 Jun; 32(5):1051-61. PubMed ID: 3926011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphofunctional study of the effects of fetal exposure to cyproterone acetate on the hypothalamo-pituitary-gonadal axis of adult rats.
    Rossi GL; Bestetti GE; Reymond MJ; Lemarchand-Béraud T
    Exp Brain Res; 1991; 83(2):349-56. PubMed ID: 1673659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of flutamide or cyproterone acetate on pituitary and testicular hormones in normal men.
    Knuth UA; Hano R; Nieschlag E
    J Clin Endocrinol Metab; 1984 Nov; 59(5):963-9. PubMed ID: 6237116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sexual maturation in male mice treated with cyproterone acetate from birth to puberty.
    Jean-Faucher C; Berger M; De Turckheim M; Veyssiere G; Jean C
    J Endocrinol; 1984 Jul; 102(1):103-7. PubMed ID: 6234374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The different mechanisms for suppression of pituitary and testicular function.
    Sandow J; Engelbart K; von Rechenberg W
    Med Biol; 1986; 63(5-6):192-200. PubMed ID: 3010006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of cyproterone acetate on serum testosterone, LH, FSH, and prolactin in male sexual offenders.
    Jeffcoate WJ; Matthews RW; Edwards CR; Field LH; Besser GM
    Clin Endocrinol (Oxf); 1980 Aug; 13(2):189-95. PubMed ID: 6777092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyproterone acetate, testosterone, LH, FSH, and prolactin levels in plasma after intramuscular application of cyproterone acetate in patients with prostatic cancer.
    Rost A; Schmidt-Gollwitzer M; Hantelmann W; Brosig W
    Prostate; 1981; 2(3):315-22. PubMed ID: 6458025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of PRL secretion by combined treatment with cyproterone acetate and ethinylestradiol.
    Valenti G; Vescovi PP; Gerra G; Rastelli G; Butturini U
    J Endocrinol Invest; 1985 Jun; 8(3):269-72. PubMed ID: 3161934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rat prostatic weight regression in reaction to ketoconazole, cyproterone acetate, and RU 23908 as adjuncts to a depot formulation of gonadotropin-releasing hormone analogue.
    Lamberts SW; Uitterlinden P; de Jong FH
    Cancer Res; 1988 Nov; 48(21):6063-8. PubMed ID: 2844399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of chronic ethanol diet on pituitary-testicular function of the rat.
    Salonen I; Huhtaniemi I
    Biol Reprod; 1990 Jan; 42(1):55-62. PubMed ID: 2155675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo studies on the antiandrogenic effects of cimetidine versus cyproterone acetate in rats.
    Baba S; Paul HJ; Pollow K; Janetschek G; Jacobi GH
    Prostate; 1981; 2(2):163-74. PubMed ID: 6458024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors in the control of prolactin, growth hormone and gonadotropin secretion in prepubertal rats.
    González LC; Pinilla L; Tena-Sempere M; Aguilar E
    J Endocrinol; 1999 Sep; 162(3):417-24. PubMed ID: 10467233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of low doses of cyproterone acetate on sperm morphology and some other parameters of reproduction in normal men.
    Fredricsson B; Carlström K
    Andrologia; 1981; 13(4):369-75. PubMed ID: 6456681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of a GnRH agonist with an antiandrogen or bromocriptine in the treatment of prostatic cancer; slight potentiation of antigonadal effects.
    Huhtaniemi I; Parvinen M; Venho P; Rannikko S
    Int J Androl; 1991 Oct; 14(5):374-86. PubMed ID: 1839022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of cyproterone acetate on the reproductive tract and pituitary-gonadal axis of the golden hamster.
    Balbontin JB; Ferrario M
    Andrologia; 1993; 25(5):289-92. PubMed ID: 8250293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of pulsatile gonadotropin-releasing hormone on the release of luteinizing hormone and follicle-stimulating hormone in vitro by anterior pituitaries from lactating and cycling rats.
    Smith MS
    Endocrinology; 1982 Mar; 110(3):882-91. PubMed ID: 6799281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical use of antiandrogens in the female].
    Moltz L; Schwartz U; Hammerstein J
    Gynakologe; 1980 Mar; 13(1):1-17. PubMed ID: 6299908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low dose of cyproterone acetate and testosterone enanthate for contraception in men.
    Meriggiola MC; Bremner WJ; Costantino A; Di Cintio G; Flamigni C
    Hum Reprod; 1998 May; 13(5):1225-9. PubMed ID: 9647551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The response to gonadotropin-releasing hormone in hirsutism after treatment with cyproterone acetate].
    Kocijancic A; Pfeifer M; Prezelj J; Meden-Vrtovec H; Vrhovec I
    Jugosl Ginekol Opstet; 1982; 22(1-2):16-9. PubMed ID: 6215543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.